Clinical Trials Logo

Clinical Trial Summary

Fetal medicine in China is still a new, young discipline, and the development is very rapid. After nearly 10 years of development, the clinical diagnosis and treatment guidelines of some complicated twin diseases has been established , but they are still needed to be improved. Through this study, the investigators expect to achieve better prediction indicators and early intrauterine precise diagnosis of complicated twin diseases. Also, better procedures of implementing effective intrauterine intervention and assessing the safety and effectiveness of intrauterine intervention are anticipated to be established.


Clinical Trial Description

A better guideline for complicated twin diseases are anticipated to be established in China. Molecular genetics and imaging technology are applied to evaluate the outcome and prognosis of intrauterine intervention for complex twin diseases. 3D printing technology is used to assist the preoperative evaluation of fetal intrauterine intervention. Better fetal intrauterine intervention technique and prognosis evaluation are expected to be established. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03650985
Study type Interventional
Source Shengjing Hospital
Contact Caixia Liu
Phone 86-18902451716
Email liucx1716@163.com
Status Recruiting
Phase N/A
Start date August 31, 2018
Completion date August 2022

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04952415 - the Prognosis of Fetoscopy Treatment of Twin Transfusion Syndrome
Recruiting NCT05952583 - Selective Fetal Growth Restriction in Monochorionic Twins - an International Investigation
Recruiting NCT03331133 - Twins Born in Guangzhou
Recruiting NCT05761769 - Twin Pregnancy: a Challenge for Patients, Families and Health Professionals